fda deadline for semaglutide compounded As of February 21, 2025, the updated its drug shortage list, marking Wegovy FDA Approval: CV Risk

This has a broader population health benefit as greater access to these medicines will reduce the crippling strain obesity-related conditions have on NHS resources. In the UK, generic competition typically reduces prices paid by the NHS by as much as 80% to 90% after loss of exclusivity, according to the BGMA

Bachilo and Kumar recommend asking your doctor about the expected duration of GLP-1 therapy, what factors influence that timeline, and how to safely transition off the medication if needed

Explain the concept of carbohydrate counting and its flexibility in food choices

Evidence gap Large-scale, long-duration RCTs of subcutaneous NAD+ for wellness or longevity endpoints have not been published as of June 2026